Drugmakers will continue to face challenges in Greece due to the country's poor governance of the pharmaceutical market. The brunt of this has been felt by patients, with widespread medicine shortages, and also by pharmaceutical firms, with rising ...
 |
| READ THE ORIGINAL POST AT reports.pr-inside.com |